I'm not debating that. My point was that the treatment choices for osteoporosis are far from perfect and there are other approaches being currently explored to keep bones healthy that seem to show promise. And may yield far better treatment options. Until then the risks of drug-induced cancer of the parathyroid or osteonecrosis or DVTs are among the known adverse effects that patients need to consider and ask their physicians about how to design a treatment plan. Science still cannot explain why one drug can help lumbar spine vertebrae slow shedding of old bone but not hip and femur while another drug does the exact opposite. Or the exact mechanism by which bisphosphonates actually cause longitudinal femur fractures. But current research may provide better choices in the future and that is hopeful.